Current Event 2022

WEEK OF OCTOBER 31, 2022

Major Japan Week Conference. Details are forthcoming.

Healthcare Symposium on May 24, 2022

The Future of Precision and Predictive Healthcare

Shot of a scientist using a virtual reality headset while conducting research in a laboratory
WHEN

US
May 24, 2022
4:00–6:30 PM (PDT)

JAPAN
May 25, 2022
8:00–10:30 AM (JT)

WHERE

ONLINE VIA ZOOM

*OR*

IN-PERSON AT PLUG AND PLAY SUNNYVALE

KEYNOTE SPEAKER
lloyd-minor_profilephoto
Lloyd B. Minor, MD

Carl And Elizabeth Naumann Professorship for the Dean of The Stanford School of Medicine, Professor of Otolaryngology – Head & Neck Surgery (Ohns) and, by Courtesy, of Neurobiology and of Bioengineering.

Bio

One important quest of healthcare is to prevent adverse events in individuals. The pandemic has been a worldwide tragedy, but it has brought a huge growth of telemedicine. Meanwhile, the proliferation of sensors and AI have increased availability of real time monitoring, and the development of correlations of an individual’s data to health outcomes. Combining all these factors and other data such as genetic sequencing and the Electronic Health Record (EHR) offer the opportunity to predict adverse events in patients. We will have Dean Lloyd Minor of the Stanford University School of Medicine as our keynote speaker and will also feature Japanese companies interested in products and technologies that might advance this concept and also interested in expanding their business and strategic partnerships in the US and globally.

医療の重要な課題の一つは、予期せぬ事態にどう対応していくかです。新型コロナは世界中に大変な影響をもたらしましたが、逆にそれは遠隔治療・電話診療の急速な成長をもたらしました。センサーやAIの急速な広がりはリアルタイムモニタリングを可能にし、個人の診療データと健康維持の相関性を高めることにつながっています。こうした要因や遺伝子配列解析、電子医療記録などが相まって患者の将来の問題発生をよりよく予測することが可能になります。本シンポジウムでは、スタンフォード大学医学部長であるロイド・マイナー教授をキーノートスピーカーにお迎えして『先制医療と予知医療の将来』についてお話しいただきます。また、今回の基本コンセプトを推進するのに役立つ製品やテクノロジーに関心を持つ日本企業から、米国や世界でどのように事業展開しようとしているのか、どのような戦略的パートナーシップを考えているのか等について伺います。登壇日本企業は、シスメックス、帝人ファーマ、富士フィルム、富士通、日本生命、日東電工等を予定しています。

— OUR AMAZING PRESENTERS —

— HEALTHCARE SYMPOSIUM AGENDA —

US: 3:45 – 4:00 PM (PDT)
Japan: 7:45 – 8:00 AM

ZOOM TUTORIAL  – Japan Society of Northern California

US: 4:00 – 4:05 PM (PDT)
Japan: 8:00 – 8:05 AM

WELCOME AND OPENING REMARKS

Jack Moorman | Chairman, US-Japan Healthcare Connection

US: 4:05 – 4:10 PM (PDT)
Japan: 8:05 – 8:10 AM

SPECIAL REMARKS

Hiroshi Kawamura | Consul General of Japan in San Francisco

US: 4:10 – 4:11 PM (PDT)
Japan: 8:10 – 8:11 AM

INTRODUCTION OF KEYNOTE SPEAKER

Fumiaki Ikeno, MD | Program Director (U.S.) Japan Biodesign, Stanford Biodesign, Cardiovascular Medicine, Stanford University

US: 4:11 – 4:51 PM (PDT)
Japan: 8:11 – 8:51 AM

KEYNOTE SPEECH

Followed by Q&A session moderated by Dr. Fumiaki Ikeno

Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Dean of the Stanford University School of Medicine and author of the 2020 book “Discovering Precision health: Predict, Prevent, and Cure to Advance Health and Well-Being.”

US: 4:51 – 5:04 PM (PDT)
Japan: 8:51 – 9:04 AM

BREAK / COMMERCIALS

US: 5:04 – 5:13 PM (PDT)
Japan: 9:04 – 9:13 AM

SYSMEX

Sysmex is a global leader in diagnostics based in Kobe, Japan, with a presence in more than 190 countries. Founded in 1968, Sysmex has deep expertise in the fields of hematology, hemostasis and immunochemistry, and has expanded in the life science domain. We are an integrated and market-leading manufacturer of instruments, reagents and software needed for in vitro diagnostic testing of blood, urine and other samples. As a leader in diagnostics, we believe that Sysmex can help lead a revolution in personalized healthcare, and thereby help people around the world achieve healthier lives. We are looking for partners who share our commitment to our mission: “Shaping the advancement of healthcare.”

Yuuki Watanabe is the president of Sysmex R&D Centers America, Inc. (RDCA), a wholly owned subsidiary of Sysmex Corporation focused on realizing preventive medicine and bringing new clinical applications from the US to the rest of the world via the Sysmex organization. Yuuki is responsible for all R&D activities in North America and Latin America, and developing new businesses in diagnostic, preventive and therapeutic medicine. He leads growth initiatives related to digital health and digital therapeutics, as well as regenerative medicine and reagent development for IVD. In that capacity, he is particularly eager to meet with early-stage companies developing innovative new digital diagnostic and therapeutic solutions.

US: 5:13 – 5:17 PM (PDT)
Japan: 9:13 – 9:17 AM

TEIJIN
Teijin Pharma Ltd. is a Japanese healthcare company, primarily engaged in the research, development, manufacture and marketing of medical devices and pharmaceuticals. Our mission is to improve the quality of life of patients. As for the medical device, we have a supply network throughout Japan like that of DME providers in the U.S., and its strength is in patient care, including call center that is available 24 hours a day. We have top level market share in Japan for oxygen concentrators for home oxygen therapy and CPAP ventilators for sleep apnea syndrome. We will further improve the quality of life of patients by deploying cutting-edge medical devices and pharmaceuticals from the U.S. and other countries to the Japanese market.

US: 5:17 – 5:26 PM (PDT)
Japan: 9:17 – 9:26 AM

FUJIFILM

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting-edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions, and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic, and imaging technologies. For the year ended March 31, 2022, the company had global revenues of $18 billion (unofficial), at an exchange rate of 130 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.

Aki Machida was born in Japan but has been living in Silicon Valley for 22 years. While working in product marketing at HP and Agilent Technologies, his market-centric idealization was well regarded, having led the business to success since early 90s. He defined and product-released a linear encoder that dominated the inkjet printer market. The collaboration project with Nichia to convert traffic lights to LED was his second marketing success. Persistent effort in optical mouse sensor marketing disrupted the computer mouse market in Asia.
His chip-on-board camera module design was adopted by multiple mobile phone companies.
After working at two display startups for 12 years in total, he joined Fujifilm in 2019 as the Open Innovation Hub Manager. He has a wonderful wife and two bilingual children. He enjoys gardening with fruit trees in the backyard and fixing the house every weekend, which is as old as he is.

US: 5:26 – 5:35 PM (PDT)
Japan: 9:26 – 9:35 AM

FUJITSU
Fujitsu is the leading Japanese global information and communication technology company, offering a wide range of technology products, solutions and services. We build new possibilities by connecting people, technology and ideas, creating a more sustainable world where anyone can advance their dreams.

Kentaro Murase is a research manager in Converging Technologies Laboratories at Fujitsu Research. He has been engaged in research and development of signal processing technologies for more than two decades at Fujitsu. Currently, he is leading the development team of facial expression recognition. He also focus on expanding application of human sensing technologies overseas.

US: 5:35 – 5:43 PM (PDT)
Japan: 9:35 – 9:43 AM

NIPPON LIFE
Nippon Life has collaborated with a number of startups to support their expansion into Japan since entering Silicon Valley in 2016, and in 2020, launched a CVC to start investment activities. It has $100m fund for early stage InsureTech, Healthtech and Fintech startups. Its healthcare business in Japan is branded as Wellness-star and it has started to provide services for companies and employees to support health management. Now, it is aiming to expand its business to local community and individuals. It analyzes employee health and medical information to create reports, and provide various programs to help employees and local residents become healthier. Its method has already been adopted by 120 companies and Nippon Life holds the health data of 2 million employees. Focus areas are early detection and prevention of diabetes, cancer, heart disease, brain disease, dementia, mental health as well as health data analysis. Nippon Life believes that digital health is the key to supporting people’s health.

Yoshinori Kamiya is the Head of the Silicon Valley Team from Nippon Life Insurance. He facilitates Nippon Life’s innovation activities by leveraging his past experience in new business launches and channel strategy planning. Yoshinori joined Nippon Life Insurance in 1995. In 2018, he led the launch of the healthcare business in the company, and has been the Silicon Valley Head since 2020. Nippon Life’s task in Silicon Valley is to bring cutting-edge technologies and business models to Japan, Asia and other markets.

US: 5:43 – 5:52 PM (PDT)
Japan: 9:43 – 9:52 AM

NITTO

Nitto Denko is a BtoB manufacturer with businesses everywhere—electronics, automotive, medical, and membrane are just a few examples of the 70 industries we do business in.Miho Tsukamoto is a Business Development Manager at Nitto Innovations, Inc., a wholly owned subsidiary of Nitto Denko Corporation. She has extensive experience in business development, corporate strategies, and sales & marketing. In her current position, she is launching new businesses across different fields in collaboration with startups. Having moved to Silicon Valley recently, she is particularly scouting for innovative startups to collaborate with in the fields of mobility and healthcare, among others. She loves the excitement of launching new businesses in collaboration with great partners!

Miho Tsukamoto is a Business Development Manager at Nitto Innovations, Inc., a wholly owned subsidiary of Nitto Denko Corporation. She has extensive experience in business development, corporate strategies, and sales & marketing. In her current position, she is launching new businesses across different fields in collaboration with startups. Having moved to Silicon Valley recently, she is particularly scouting for innovative startups to collaborate with in the fields of mobility and healthcare, among others. She loves the excitement of launching new businesses in collaboration with great partners!

US: 5:52 – 5:57 PM (PDT)
Japan: 9:52 – 9:57 AM

CLOSING REMARKS

Takahide Akiyama | President, Japan Society of Northern California

US: 5:57 – 6:40 PM (PDT)
Japan: 9:57 – 10:40 AM

BREAKOUT SESSIONS & NETWORKING

Breakout sessions with each presenting company (Q&A and networking)